Overview / Abstract: |
This interactive digital activity combines animated slides and expert video commentary on molecular testing recommendations, guidance on interpreting molecular testing results, and clinical trial evidence to enhance the implementation of precision medicine in the care of patients with EGFR-mutant NSCLC. Through this education, learners explore best practices for EGFR mutation testing, application of clinical trial data to treatment selection, and the role of concurrent mutations in the prognosis and response to therapy of patients with EGFR-mutant NSCLC. |
Expiration |
Dec 30, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.25 |
Accreditation |
ACCME, ABPath MOC, MIPS QPP |
Presenters / Authors / Faculty |
Maria E. Arcila, MD Justin Gainor, MD |
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Pathology |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Lilly. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Lilly, justin gainor, maria arcila, pathology, oncology, EGFR-Mutant, EGFR, NSCLC, TP53, biomarker testing, multidisciplinary, Molecular Diagnostic Studies, genetic alteration, mutation, NCCN, targeted therapy, metastatic, histologic, liquid biopsy, tissue acquisition, Anaplastic lymphoma kinase, ALK, ROS proto-oncogene, TKI therapy, KRAS mutation, Neurotrophic Free CE CME |